HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA.

Abstract
Mucopolysaccharidosis type IIIA (MPS IIIA) is a lysosomal storage disorder resulting from the deficit of the N-sulfoglucosamine sulfohydrolase (SGSH) enzyme that leads to accumulation of partially-degraded heparan sulfate. MPS IIIA is characterized by severe neurological symptoms, clinically presenting as Sanfilippo syndrome, for which no effective therapy is available. The lysosomal SGSH enzyme is conserved in Drosophila and we have identified increased levels of heparan sulfate in flies with ubiquitous knockdown of SGSH/CG14291. Using neuronal specific knockdown of SGSH/CG14291 we have also observed a higher abundance of Lysotracker-positive puncta as well as increased expression of GFP tagged Ref(2)P supporting disruption to lysosomal function. We have also observed a progressive defect in climbing ability, a hallmark of neurological dysfunction. Genetic screens indicate proteins and pathways that can functionally modify the climbing phenotype, including autophagy-related proteins (Atg1 and Atg18), superoxide dismutase enzymes (Sod1 and Sod2) and heat shock protein (HSPA1). In addition, reducing heparan sulfate biosynthesis by knocking down sulfateless or slalom expression significantly worsens the phenotype; an important observation given that substrate inhibition is being evaluated clinically as a treatment for MPS IIIA. Identifying the cellular pathways that can modify MPS IIIA neuropathology is an essential step in the development of novel therapeutic approaches to prevent and/or ameliorate symptoms in children with Sanfilippo syndrome.
AuthorsDani L Webber, Amanda Choo, Laura J Hewson, Paul J Trim, Marten F Snel, John J Hopwood, Robert I Richards, Kim M Hemsley, Louise V O'Keefe
JournalExperimental neurology (Exp Neurol) Vol. 303 Pg. 38-47 (05 2018) ISSN: 1090-2430 [Electronic] United States
PMID29408731 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Inc. All rights reserved.
Chemical References
  • Drosophila Proteins
  • RNA, Messenger
  • Green Fluorescent Proteins
  • Heparitin Sulfate
  • Hydrolases
  • N-sulfoglucosamine sulfohydrolase
Topics
  • Age Factors
  • Animals
  • Animals, Genetically Modified
  • Autophagy (genetics)
  • Brain (pathology)
  • Disease Models, Animal
  • Drosophila
  • Drosophila Proteins (genetics, metabolism)
  • Gene Expression Regulation (genetics)
  • Green Fluorescent Proteins (genetics, metabolism)
  • Heparitin Sulfate (metabolism)
  • Hydrolases (genetics, metabolism)
  • Larva (genetics, metabolism)
  • Locomotion (genetics)
  • Mucopolysaccharidosis III (complications, drug therapy, genetics, pathology)
  • Mutation (genetics)
  • Neurons (metabolism)
  • Psychomotor Disorders (etiology)
  • RNA Interference (physiology)
  • RNA, Messenger (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: